Release date: 2016-03-23
Apira Science, Inc. continues its global expansion and its iGrow hair growth system has been approved in China. Currently, iGrow is the only hair growth device approved by the China Food and Drug Administration (CFDA) and the only one approved by the US FDA and CFDA. Apira will partner with China National Pharmaceutical Co., Ltd., one of China's largest private pharmaceutical companies, to distribute iGrow in China, which has been the exclusive distributor of Apira in China since 2013.
Apira Science President Jeff Braile said: "After this approval, Apira was able to enter China's fast-growing hair loss treatment market, and iGrow became the only proven hair loss treatment device that Chinese consumers can buy. We look forward to the limited liability with China National Medicine. The company collaborates to provide this clinically proven low-power laser treatment (LLLT) for individuals with genetic alopecia in China."
Ma Teng, president of China National Medicine Co., Ltd. said: "In view of China's huge population and huge demand for hair loss treatment, the launch of iGrow hair growth system will be welcomed by Chinese hospitals and medical centers. Our cooperation highlights the partnership. Real power."
CFDA approval increases iGrow's visibility in China's $33.5 billion ($5.5 billion) hair treatment market, with sales of Western hair loss treatment products increasing by 90% from 2007 to 2012. Prior to this announcement, iGrow was approved in several Asian countries, including South Korea, Thailand and Singapore. China is the latest country to join the 12 iGrow approved markets, including the United States, Canada, Mexico, Hong Kong and India. The iGrow approved country also includes all 28 EU countries, Turkey and the United Kingdom.
The iGrow Hair Growth System is an innovative, safe, effective, hands-free LLLT hair growth device that has been approved by the FDA for home use. Clinical studies have shown that iGrow's patented red light technology (consisting of an efficient combination of red laser and LED diodes) after 16 weeks of treatment, hair growth of 37%, the total amount of hair growth nearly doubled than the hand-held laser comb and The brush is 10 weeks faster.
For further information on the iGrow Hair Growth System, please visit
About Apira Science, Inc.
Apira Science, Inc. has been a leader in low power laser therapy (LLLT) for more than a decade. Its iGrow hair growth platform is based on the company's expertise and innovation in LLLT applications to provide simple, safe and effective hair growth treatment.
Original search
"Apira Science's iGrow Becomes First Hair Growth Device Cleared by China Food and Drug Administration (CFDA)"
Source: Wenchuan Business News
face mask used for daily protection, with 3 ply non-woven fabric, It can effectively filter droplets and block direct contact between virus and human body. The fabric is breathable and comfortable,it won't cause skin allergy.
We are professional manufacture of medical equipment with 6 years experiance.
The company conscientiously implements the "Regulations on the supervision and administration of medical devices" and other laws and regulations, and adopts a scientific management mode. The company has successively passed the EU CE certification and CFDA "medical device production quality management specification" assessment.
Adhering to the concept of "quality first, integrity-based, continuous change and long-term commitment", the company is committed to providing customers with high-quality, high safety performance products and high-quality services.
Disposible Face Mask,Face Mask With Logo,Face Mask With Designs,Disposable Medical Face Mask
Shanghai Rocatti Biotechnology Co.,Ltd , https://www.shljdmedical.com